Literature DB >> 15168085

The management of extra-abdominal desmoid tumours.

Amit Duggal1, Ian C Dickinson, Scott Sommerville, Price Gallie.   

Abstract

We performed a retrospective analysis of 35 cases of desmoid tumours (aggressive fibromatoses) that underwent treatment at our institutions between 1987 and 2002. The purpose was to evaluate the rate of local recurrence of desmoid tumours treated with surgical excision, to assess the impact of surgical margins on local recurrence and to define the role of radiotherapy in the treatment. Nine patients experienced a recurrence at an average of 16 months after initial treatment. Seven of the 15 patients with a less-than-wide margin had a local recurrence. Comparatively, only two of the 20 patients with a wide margin had a local recurrence. Thirty-three of the 35 patients were disease free at the last follow-up. We recommend wide excision with clear margins whenever possible. Marginal resections are appropriate when wide excision would severely compromise the function of the limb. Surgical resections and selective supplementation of adjuvant radiotherapy give excellent control rates.

Entities:  

Mesh:

Year:  2004        PMID: 15168085      PMCID: PMC3456932          DOI: 10.1007/s00264-004-0571-0

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  22 in total

1.  Radiation therapy for aggressive fibromatosis. The Experience at the University of Florida.

Authors:  W M McCollough; J T Parsons; R van der Griend; W F Enneking; T Heare
Journal:  J Bone Joint Surg Am       Date:  1991-06       Impact factor: 5.284

2.  Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy.

Authors:  M T Ballo; G K Zagars; A Pollack; P W Pisters; R A Pollack
Journal:  J Clin Oncol       Date:  1999-01       Impact factor: 44.544

3.  The desmoid tumor. Not a benign disease.

Authors:  M C Posner; M H Shiu; J L Newsome; S I Hajdu; J J Gaynor; M F Brennan
Journal:  Arch Surg       Date:  1989-02

4.  The enigma of desmoid tumors.

Authors:  J J Lewis; P J Boland; D H Leung; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

5.  The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor.

Authors:  J J Reitamo; T M Scheinin; P Häyry
Journal:  Am J Surg       Date:  1986-02       Impact factor: 2.565

6.  Desmoid tumors of the trunk and extremity.

Authors:  C P Karakousis; J Mayordomo; G C Zografos; D L Driscoll
Journal:  Cancer       Date:  1993-09-01       Impact factor: 6.860

7.  Extra-abdominal desmoid tumors.

Authors:  M G Rock; D J Pritchard; H M Reiman; E H Soule; R C Brewster
Journal:  J Bone Joint Surg Am       Date:  1984-12       Impact factor: 5.284

8.  Combination chemotherapy for desmoid tumors.

Authors:  Scott H Okuno; John H Edmonson
Journal:  Cancer       Date:  2003-02-15       Impact factor: 6.860

9.  External beam radiotherapy for primary and adjuvant management of aggressive fibromatosis.

Authors:  Robert A Zlotecki; Mark T Scarborough; Christopher G Morris; B Hudson Berrey; D Scott Lind; William F Enneking; Robert B Marcus
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-09-01       Impact factor: 7.038

10.  Desmoid tumors: a clinical review of 30 patients with more than 20 years' follow-up.

Authors:  B P Mikael Dalén; Peter M Bergh; Björn U P Gunterberg
Journal:  Acta Orthop Scand       Date:  2003-08
View more
  20 in total

1.  Wide resection of the upper right hemithorax combined with amputation of the right arm for a recurrent desmoid tumor.

Authors:  Yasushi Sakamaki; Tetsuo Kido; Motoaki Yasukawa; Takashi Fujiwara; Katsuki Kuwae; Motomu Maeda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-08

2.  Intracranial aggressive fibromatosis presenting as panhypopituitarism and diabetes insipidus.

Authors:  A Gursoy; M Cesur; B Aktaş; G Utkan; V Tonyukuk Gedik; Mf Erdogan; N Kamel
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

3.  Evaluating causes of death in familial adenomatous polyposis.

Authors:  Fábio Guilherme C M de Campos; Rodrigo Oliva Perez; Antônio Rocco Imperiale; Víctor Edmond Seid; Sérgio Carlos Nahas; Ivan Cecconello
Journal:  J Gastrointest Surg       Date:  2010-07-30       Impact factor: 3.452

Review 4.  Desmoid tumours of the extremities and trunk: a review of the literature.

Authors:  Emilios E Pakos; Pericles G Tsekeris; Ann C Goussia
Journal:  Int Orthop       Date:  2005-05-18       Impact factor: 3.075

5.  A massive abdominal wall desmoid tumor occurring in a laparotomy scar: a case report.

Authors:  Joseph K Wanjeri; Collins J O Opeya
Journal:  World J Surg Oncol       Date:  2011-03-22       Impact factor: 2.754

Review 6.  A systematic review of active treatment options in patients with desmoid tumours.

Authors:  X Yao; T Corbett; A A Gupta; R A Kandel; S Verma; J Werier; M Ghert
Journal:  Curr Oncol       Date:  2014-08       Impact factor: 3.677

7.  Treatment and follow-up strategies in desmoid tumours: a practice guideline.

Authors:  M Ghert; X Yao; T Corbett; A A Gupta; R A Kandel; S Verma; J Werier
Journal:  Curr Oncol       Date:  2014-08       Impact factor: 3.677

8.  Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors.

Authors:  Alexander J F Lazar; Daniel Tuvin; Shohrae Hajibashi; Sultan Habeeb; Svetlana Bolshakov; Empar Mayordomo-Aranda; Carla L Warneke; Dolores Lopez-Terrada; Raphael E Pollock; Dina Lev
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

9.  [Long-term effectiveness of "West China Classification" guided surgical treatment of desmoid-type fibromatosis in shoulder girdle].

Authors:  Sisi Zhou; Fan Tang; Li Min; Yi Luo; Yong Zhou; Hong Duan; Chongqi Tu
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-06-15

10.  Extra-abdominal desmoid tumours: a review of the literature.

Authors:  A P Molloy; B Hutchinson; G C O'Toole
Journal:  Sarcoma       Date:  2012-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.